These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Preparation, characterization, and antitumor activities of folate-decorated docetaxel-loaded human serum albumin nanoparticles. Jiang S; Gong X; Zhao X; Zu Y Drug Deliv; 2015 Feb; 22(2):206-13. PubMed ID: 24471890 [TBL] [Abstract][Full Text] [Related]
4. Biotin/Folate-decorated Human Serum Albumin Nanoparticles of Docetaxel: Comparison of Chemically Conjugated Nanostructures and Physically Loaded Nanoparticles for Targeting of Breast Cancer. Nateghian N; Goodarzi N; Amini M; Atyabi F; Khorramizadeh MR; Dinarvand R Chem Biol Drug Des; 2016 Jan; 87(1):69-82. PubMed ID: 26216713 [TBL] [Abstract][Full Text] [Related]
5. In vivo antitumor effects of chitosan-conjugated docetaxel after oral administration. Lee E; Kim H; Lee IH; Jon S J Control Release; 2009 Dec; 140(2):79-85. PubMed ID: 19712714 [TBL] [Abstract][Full Text] [Related]
6. A Novel Dextran-Based Dual Drug Conjugate Targeted Tumors with High Biodistribution Ratio of Tumors to Normal Tissues. Liu J; Zhang N; Wu J; Dong P; Lv H; Wang Q; Wang S; Yang H; Wang S; Li X; Hu J; Wang A; Li DJ; Shi Y Int J Nanomedicine; 2022; 17():4895-4910. PubMed ID: 36262192 [TBL] [Abstract][Full Text] [Related]
7. Targeted poly (L-γ-glutamyl glutamine) nanoparticles of docetaxel against folate over-expressed breast cancer cells. Tavassolian F; Kamalinia G; Rouhani H; Amini M; Ostad SN; Khoshayand MR; Atyabi F; Tehrani MR; Dinarvand R Int J Pharm; 2014 Jun; 467(1-2):123-38. PubMed ID: 24680951 [TBL] [Abstract][Full Text] [Related]
8. Synthesis, characterization, and in vivo efficacy evaluation of PGG-docetaxel conjugate for potential cancer chemotherapy. Yang D; Van S; Shu Y; Liu X; Ge Y; Jiang X; Jin Y; Yu L Int J Nanomedicine; 2012; 7():581-9. PubMed ID: 22334784 [TBL] [Abstract][Full Text] [Related]
9. Enhanced antitumor efficacy and decreased toxicity by self-associated docetaxel in phospholipid-based micelles. Tong SW; Xiang B; Dong DW; Qi XR Int J Pharm; 2012 Sep; 434(1-2):413-9. PubMed ID: 22698861 [TBL] [Abstract][Full Text] [Related]
10. Improved Antitumor Efficacy of a Dextran-based Docetaxel-coupled Conjugate against Triple-Negative Breast Cancer. Lv H; Jia W; Dong P; Liu J; Wang S; Li X; Hu J; Zhao L; Shi Y Curr Drug Deliv; 2024; 21(5):775-784. PubMed ID: 37349996 [TBL] [Abstract][Full Text] [Related]
12. Docetaxel-loaded-lipid-based-nanosuspensions (DTX-LNS): preparation, pharmacokinetics, tissue distribution and antitumor activity. Wang L; Liu Z; Liu D; Liu C; Juan Z; Zhang N Int J Pharm; 2011 Jul; 413(1-2):194-201. PubMed ID: 21540085 [TBL] [Abstract][Full Text] [Related]
13. Mixed Micelles as Nano Polymer Therapeutics of Docetaxel: Increased In vitro Cytotoxicity and Decreased In vivo Toxicity. Manjappa AS; Kumbhar PS; Khopade PS; Patil AB; Disouza JI Curr Drug Deliv; 2018; 15(4):564-575. PubMed ID: 28637416 [TBL] [Abstract][Full Text] [Related]
14. Pluronic F-127 Stabilised Docetaxel Nanocrystals Improve Apoptosis by Mitochondrial Depolarization in Breast Cancer Cells: Pharmacokinetics and Toxicity Assessment. Pawar VK; Gupta S; Singh Y; Meher JG; Sharma K; Singh P; Gupta A; Bora HK; Chaurasia M; Chourasia MK J Biomed Nanotechnol; 2015 Oct; 11(10):1747-63. PubMed ID: 26502638 [TBL] [Abstract][Full Text] [Related]
15. Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles. Hwang HY; Kim IS; Kwon IC; Kim YH J Control Release; 2008 May; 128(1):23-31. PubMed ID: 18374444 [TBL] [Abstract][Full Text] [Related]
16. Development of docetaxel-loaded intravenous formulation, Nanoxel-PM™ using polymer-based delivery system. Lee SW; Yun MH; Jeong SW; In CH; Kim JY; Seo MH; Pai CM; Kim SO J Control Release; 2011 Oct; 155(2):262-71. PubMed ID: 21704664 [TBL] [Abstract][Full Text] [Related]
17. Docetaxel-loaded human serum albumin (HSA) nanoparticles: synthesis, characterization, and evaluation. Qu N; Sun Y; Li Y; Hao F; Qiu P; Teng L; Xie J; Gao Y Biomed Eng Online; 2019 Jan; 18(1):11. PubMed ID: 30704488 [TBL] [Abstract][Full Text] [Related]
18. Docetaxel-loaded solid lipid nanoparticles: preparation, characterization, in vitro, and in vivo evaluations. Mosallaei N; Jaafari MR; Hanafi-Bojd MY; Golmohammadzadeh S; Malaekeh-Nikouei B J Pharm Sci; 2013 Jun; 102(6):1994-2004. PubMed ID: 23558514 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and therapeutic evaluation of an aptide-docetaxel conjugate targeting tumor-associated fibronectin. Kim H; Lee Y; Lee IH; Kim S; Kim D; Saw PE; Lee J; Choi M; Kim YC; Jon S J Control Release; 2014 Mar; 178():118-24. PubMed ID: 24462899 [TBL] [Abstract][Full Text] [Related]
20. Preclinical pharmacokinetic, biodistribution, and anti-cancer efficacy studies of a docetaxel-carboxymethylcellulose nanoparticle in mouse models. Ernsting MJ; Tang WL; MacCallum NW; Li SD Biomaterials; 2012 Feb; 33(5):1445-54. PubMed ID: 22079003 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]